Alpha-interferon in the treatment of subacute sclerosing panencephalitis
- PMID: 9430312
- DOI: 10.1177/088307389701200803
Alpha-interferon in the treatment of subacute sclerosing panencephalitis
Abstract
Subacute sclerosing panencephalitis is an inexorably progressive disease with no effective therapy. Recent trials of intrathecal and intraventricular alpha-interferon yielded controversial results. We tried intrathecal or intraventricular alpha-interferon in four patients with subacute sclerosing panencephalitis. None of them had evidence of improvement. We reviewed the previously published studies on the use of alpha-interferon in subacute sclerosing panencephalitis. Further international collaborative studies are needed to determine the role of alpha-interferon in the treatment of subacute sclerosing panencephalitis.
Comment in
-
Treatment of subacute sclerosing panencephalitis.J Child Neurol. 1997 Nov;12(8):469-70. doi: 10.1177/088307389701200801. J Child Neurol. 1997. PMID: 9430310 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources